105 related articles for article (PubMed ID: 25747810)
1. Primary Cutaneous Polymorphic EBV-Associated Posttransplant Lymphoproliferative Disorder After a Renal Transplant and Review of the Literature.
Ferguson NN; Thomas CP; Hohl RJ; Syrbu SI; Stone MS; Wanat KA
Am J Dermatopathol; 2015 Oct; 37(10):790-4. PubMed ID: 25747810
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases.
Nash RA; Dansey R; Storek J; Georges GE; Bowen JD; Holmberg LA; Kraft GH; Mayes MD; McDonagh KT; Chen CS; Dipersio J; Lemaistre CF; Pavletic S; Sullivan KM; Sunderhaus J; Furst DE; McSweeney PA
Biol Blood Marrow Transplant; 2003 Sep; 9(9):583-91. PubMed ID: 14506660
[TBL] [Abstract][Full Text] [Related]
3. Association of antiviral prophylaxis and rituximab use with posttransplant lymphoproliferative disorders (PTLDs): A nationwide cohort study.
Walti LN; Mugglin C; Sidler D; Mombelli M; Manuel O; Hirsch HH; Khanna N; Mueller N; Berger C; Boggian K; Garzoni C; Neofytos D; van Delden C; Hirzel C;
Am J Transplant; 2021 Jul; 21(7):2532-2542. PubMed ID: 33289340
[TBL] [Abstract][Full Text] [Related]
4. Post-transplant lymphoproliferative disorders following kidney transplantation: A literature review with updates on risk factors, prognostic indices, screening strategies, treatment and analysis of donor type.
Ergisi M; Ooi B; Salim O; Papalois V
Transplant Rev (Orlando); 2024 Apr; 38(2):100837. PubMed ID: 38430887
[TBL] [Abstract][Full Text] [Related]
5. Extremely delayed-onset post-transplant lymphoproliferative disorder in a renal transplant patient.
Holland E; Altshuler E; Franke AJ
BMJ Case Rep; 2022 Aug; 15(8):. PubMed ID: 35977750
[TBL] [Abstract][Full Text] [Related]
6. Rituximab for posttransplant lymphoproliferative disorder - therapeutic, preemptive, or prophylactic?
Storek J; Lindsay J
Bone Marrow Transplant; 2024 Jan; 59(1):6-11. PubMed ID: 38001229
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathogenesis of B-cell posttransplant lymphoproliferative disorder: what do we know so far?
Morscio J; Dierickx D; Tousseyn T
Clin Dev Immunol; 2013; 2013():150835. PubMed ID: 23690819
[TBL] [Abstract][Full Text] [Related]
8. Successful Treatment of Central Nervous System Involvement in Posttransplant EBV-related Lymphoproliferative Disease With Intrathecal Rituximab Therapy.
Aslan F; Güler S; Sezgin Evim M; Aslier M; Yazici Z; Öztürk Nazlioğlu H; Meral Güneş A
J Pediatr Hematol Oncol; 2023 Jul; 45(5):e628-e630. PubMed ID: 36730621
[TBL] [Abstract][Full Text] [Related]
9. Gastric Burkitt's monomorphic post-transplant lymphoproliferative disorder after kidney transplantation: A case report.
Yoshimura Y; Suwabe T; Fujiki A; Kaji D; Asano-Mori Y; Oba Y; Mizuno H; Yamanouchi M; Tanaka K; Hasegawa E; Miki K; Yokoyama T; Namamura Y; Ishii Y; Yamashita S; Kono K; Kinowaki K; Takazawa Y; Sawa N; Ubara Y
Clin Nephrol; 2024 May; 101(5):250-256. PubMed ID: 38329919
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Post-Transplant Lymphoproliferative Disorder (PTLD) Outcomes with Epstein-Barr Virus (EBV) Assessments-A Single Tertiary Referral Center Experience and Review of Literature.
Lau E; Moyers JT; Wang BC; Jeong ISD; Lee J; Liu L; Kim M; Villicana R; Kim B; Mitchell J; Kamal MO; Chen CS; Liu Y; Wang J; Chinnock R; Cao H
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33669937
[TBL] [Abstract][Full Text] [Related]
11. Spectrum of Posttransplant Lymphoproliferations in NSG Mice and Their Association With EBV Infection After Engraftment of Pediatric Solid Tumors.
Tillman H; Vogel P; Rogers T; Akers W; Rehg JE
Vet Pathol; 2020 May; 57(3):445-456. PubMed ID: 32202225
[TBL] [Abstract][Full Text] [Related]
12. Acute Airway Obstruction: An Unusual Presentation of Posttransplant Lymphoproliferative Disorder in a Renal Transplant Recipient.
Aggarwal J; Kumar DJ; Rathore V; Mehta R; Kumar A; Ravina M
Exp Clin Transplant; 2024 Apr; 22(4):307-310. PubMed ID: 38742322
[TBL] [Abstract][Full Text] [Related]
13. Durable immunity to EBV after rituximab and third-party LMP-specific T cells: a Children's Oncology Group study.
Wistinghausen B; Toner K; Barkauskas DA; Jerkins LP; Kinoshita H; Chansky P; Pezzella G; Saguilig L; Hayashi RJ; Abhyankar H; Scull B; Karri V; Tanna J; Hanley P; Hermiston ML; Allen CE; Bollard CM
Blood Adv; 2024 Mar; 8(5):1116-1127. PubMed ID: 38163318
[TBL] [Abstract][Full Text] [Related]
14. Characterization and clinical impact of the tumor microenvironment in post-transplant aggressive B-cell lymphomas.
Leivonen SK; Friman T; Autio M; Vaittinen S; Jensen AW; D'Amore F; Hamilton-Dutoit SJ; Holte H; Beiske K; Kovanen PE; Räty R; Leppä S
Haematologica; 2023 Nov; 108(11):3044-3057. PubMed ID: 37259566
[TBL] [Abstract][Full Text] [Related]
15. T-Cell Lymphoproliferative Disorders Following Allogeneic Bone Marrow Transplant: A Report of Two Cases and a Literature Review.
Prabhakar N; Chiang H; Munoz Verdugo I; Hakimian A; Bufalino S; Bitran J
Cureus; 2024 May; 16(5):e59901. PubMed ID: 38854253
[TBL] [Abstract][Full Text] [Related]
16. Post-transplantation lymphoproliferative disorder with gastrointestinal involvement.
Inayat F; Hassan GU; Tayyab GUN; Saif MW
Ann Gastroenterol; 2018; 31(2):248-251. PubMed ID: 29507477
[TBL] [Abstract][Full Text] [Related]
17. Multimodality imaging features, treatment, and prognosis of post-transplant lymphoproliferative disorder in renal allografts: A case report and literature review.
Li J; Liu Y; Wang Z; Hu X; Xu R; Qian L
Medicine (Baltimore); 2018 Apr; 97(17):e0531. PubMed ID: 29703027
[TBL] [Abstract][Full Text] [Related]
18. T cell posttransplant lymphoproliferative disorder after kidney transplantation progressing to acute liver failure: a case report.
Cho JM; Kim YC; Min S; Kim TM; Lee H
Korean J Transplant; 2023 Dec; 37(4):299-305. PubMed ID: 38057946
[TBL] [Abstract][Full Text] [Related]
19. Ultrasound for monitoring different stages of post-transplant lymphoproliferative disorder in a transplanted kidney: A case report and review of the literature.
Du ZS; Xie XH; Hu JJ; Fang Y; Ye L
Medicine (Baltimore); 2024 Feb; 103(8):e36206. PubMed ID: 38394510
[TBL] [Abstract][Full Text] [Related]
20. Primary central nervous system post-transplantation lymphoproliferative disorder: A case report and systematic review of imaging findings.
Hoyt D; Hughes J; Liu J; Ayyad H
Radiol Case Rep; 2024 Jun; 19(6):2168-2182. PubMed ID: 38515768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
